Global Meropenem Injection Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 121
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- 0.25g/vial

- 0.5g/vial

- 1g/vial

Segment by Application

- Hospital

- Clinics

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Pfizer

- AuroMedics

- Sandoz

- Amneal Pharmaceuticals

- Sumitomo Dainippon Pharma

- Fresenius Kabi

- Mylan

- Sagent Pharmaceuticals

- Bionova Scientific

- Macleods Pharmaceuticals

- Johnlee Pharmaceuticals

- Xinya Pharm

- PKU HealthCare

- United Laboratories

- CSPC Group

- Zhejiang Hisun Pharmaceutical

- Luoxin Pharmaceutical

- Hainan Haiyao Co., Ltd.

- Shenzhen Haibin Pharmaceutical

- Chongqin Shenghuaxi

Global Meropenem Injection Market Research Report 2022

Table of Contents
1 Meropenem Injection Market Overview
1.1 Product Overview and Scope of Meropenem Injection
1.2 Meropenem Injection Segment by Type
1.2.1 Global Meropenem Injection Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 0.25g/vial
1.2.3 0.5g/vial
1.2.4 1g/vial
1.3 Meropenem Injection Segment by Application
1.3.1 Global Meropenem Injection Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Global Meropenem Injection Market Size Estimates and Forecasts
1.4.1 Global Meropenem Injection Revenue 2017-2028
1.4.2 Global Meropenem Injection Sales 2017-2028
1.4.3 Meropenem Injection Market Size by Region: 2017 Versus 2021 Versus 2028
2 Meropenem Injection Market Competition by Manufacturers
2.1 Global Meropenem Injection Sales Market Share by Manufacturers (2017-2022)
2.2 Global Meropenem Injection Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Meropenem Injection Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Meropenem Injection Manufacturing Sites, Area Served, Product Type
2.5 Meropenem Injection Market Competitive Situation and Trends
2.5.1 Meropenem Injection Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Meropenem Injection Players Market Share by Revenue
2.5.3 Global Meropenem Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Meropenem Injection Retrospective Market Scenario by Region
3.1 Global Meropenem Injection Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Meropenem Injection Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Meropenem Injection Market Facts & Figures by Country
3.3.1 North America Meropenem Injection Sales by Country
3.3.2 North America Meropenem Injection Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Meropenem Injection Market Facts & Figures by Country
3.4.1 Europe Meropenem Injection Sales by Country
3.4.2 Europe Meropenem Injection Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Meropenem Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Meropenem Injection Sales by Region
3.5.2 Asia Pacific Meropenem Injection Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Meropenem Injection Market Facts & Figures by Country
3.6.1 Latin America Meropenem Injection Sales by Country
3.6.2 Latin America Meropenem Injection Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Meropenem Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Meropenem Injection Sales by Country
3.7.2 Middle East and Africa Meropenem Injection Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Meropenem Injection Historic Market Analysis by Type
4.1 Global Meropenem Injection Sales Market Share by Type (2017-2022)
4.2 Global Meropenem Injection Revenue Market Share by Type (2017-2022)
4.3 Global Meropenem Injection Price by Type (2017-2022)
5 Global Meropenem Injection Historic Market Analysis by Application
5.1 Global Meropenem Injection Sales Market Share by Application (2017-2022)
5.2 Global Meropenem Injection Revenue Market Share by Application (2017-2022)
5.3 Global Meropenem Injection Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer Meropenem Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AuroMedics
6.2.1 AuroMedics Corporation Information
6.2.2 AuroMedics Description and Business Overview
6.2.3 AuroMedics Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.2.4 AuroMedics Meropenem Injection Product Portfolio
6.2.5 AuroMedics Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Sandoz Meropenem Injection Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Amneal Pharmaceuticals
6.4.1 Amneal Pharmaceuticals Corporation Information
6.4.2 Amneal Pharmaceuticals Description and Business Overview
6.4.3 Amneal Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Amneal Pharmaceuticals Meropenem Injection Product Portfolio
6.4.5 Amneal Pharmaceuticals Recent Developments/Updates
6.5 Sumitomo Dainippon Pharma
6.5.1 Sumitomo Dainippon Pharma Corporation Information
6.5.2 Sumitomo Dainippon Pharma Description and Business Overview
6.5.3 Sumitomo Dainippon Pharma Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Sumitomo Dainippon Pharma Meropenem Injection Product Portfolio
6.5.5 Sumitomo Dainippon Pharma Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Fresenius Kabi Meropenem Injection Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Mylan Meropenem Injection Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Sagent Pharmaceuticals
6.8.1 Sagent Pharmaceuticals Corporation Information
6.8.2 Sagent Pharmaceuticals Description and Business Overview
6.8.3 Sagent Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Sagent Pharmaceuticals Meropenem Injection Product Portfolio
6.8.5 Sagent Pharmaceuticals Recent Developments/Updates
6.9 Bionova Scientific
6.9.1 Bionova Scientific Corporation Information
6.9.2 Bionova Scientific Description and Business Overview
6.9.3 Bionova Scientific Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Bionova Scientific Meropenem Injection Product Portfolio
6.9.5 Bionova Scientific Recent Developments/Updates
6.10 Macleods Pharmaceuticals
6.10.1 Macleods Pharmaceuticals Corporation Information
6.10.2 Macleods Pharmaceuticals Description and Business Overview
6.10.3 Macleods Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Macleods Pharmaceuticals Meropenem Injection Product Portfolio
6.10.5 Macleods Pharmaceuticals Recent Developments/Updates
6.11 Johnlee Pharmaceuticals
6.11.1 Johnlee Pharmaceuticals Corporation Information
6.11.2 Johnlee Pharmaceuticals Meropenem Injection Description and Business Overview
6.11.3 Johnlee Pharmaceuticals Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Johnlee Pharmaceuticals Meropenem Injection Product Portfolio
6.11.5 Johnlee Pharmaceuticals Recent Developments/Updates
6.12 Xinya Pharm
6.12.1 Xinya Pharm Corporation Information
6.12.2 Xinya Pharm Meropenem Injection Description and Business Overview
6.12.3 Xinya Pharm Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Xinya Pharm Meropenem Injection Product Portfolio
6.12.5 Xinya Pharm Recent Developments/Updates
6.13 PKU HealthCare
6.13.1 PKU HealthCare Corporation Information
6.13.2 PKU HealthCare Meropenem Injection Description and Business Overview
6.13.3 PKU HealthCare Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.13.4 PKU HealthCare Meropenem Injection Product Portfolio
6.13.5 PKU HealthCare Recent Developments/Updates
6.14 United Laboratories
6.14.1 United Laboratories Corporation Information
6.14.2 United Laboratories Meropenem Injection Description and Business Overview
6.14.3 United Laboratories Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.14.4 United Laboratories Meropenem Injection Product Portfolio
6.14.5 United Laboratories Recent Developments/Updates
6.15 CSPC Group
6.15.1 CSPC Group Corporation Information
6.15.2 CSPC Group Meropenem Injection Description and Business Overview
6.15.3 CSPC Group Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.15.4 CSPC Group Meropenem Injection Product Portfolio
6.15.5 CSPC Group Recent Developments/Updates
6.16 Zhejiang Hisun Pharmaceutical
6.16.1 Zhejiang Hisun Pharmaceutical Corporation Information
6.16.2 Zhejiang Hisun Pharmaceutical Meropenem Injection Description and Business Overview
6.16.3 Zhejiang Hisun Pharmaceutical Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Zhejiang Hisun Pharmaceutical Meropenem Injection Product Portfolio
6.16.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.17 Luoxin Pharmaceutical
6.17.1 Luoxin Pharmaceutical Corporation Information
6.17.2 Luoxin Pharmaceutical Meropenem Injection Description and Business Overview
6.17.3 Luoxin Pharmaceutical Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Luoxin Pharmaceutical Meropenem Injection Product Portfolio
6.17.5 Luoxin Pharmaceutical Recent Developments/Updates
6.18 Hainan Haiyao Co., Ltd.
6.18.1 Hainan Haiyao Co., Ltd. Corporation Information
6.18.2 Hainan Haiyao Co., Ltd. Meropenem Injection Description and Business Overview
6.18.3 Hainan Haiyao Co., Ltd. Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Hainan Haiyao Co., Ltd. Meropenem Injection Product Portfolio
6.18.5 Hainan Haiyao Co., Ltd. Recent Developments/Updates
6.19 Shenzhen Haibin Pharmaceutical
6.19.1 Shenzhen Haibin Pharmaceutical Corporation Information
6.19.2 Shenzhen Haibin Pharmaceutical Meropenem Injection Description and Business Overview
6.19.3 Shenzhen Haibin Pharmaceutical Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Shenzhen Haibin Pharmaceutical Meropenem Injection Product Portfolio
6.19.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
6.20 Chongqin Shenghuaxi
6.20.1 Chongqin Shenghuaxi Corporation Information
6.20.2 Chongqin Shenghuaxi Meropenem Injection Description and Business Overview
6.20.3 Chongqin Shenghuaxi Meropenem Injection Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Chongqin Shenghuaxi Meropenem Injection Product Portfolio
6.20.5 Chongqin Shenghuaxi Recent Developments/Updates
7 Meropenem Injection Manufacturing Cost Analysis
7.1 Meropenem Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Meropenem Injection
7.4 Meropenem Injection Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Meropenem Injection Distributors List
8.3 Meropenem Injection Customers
9 Meropenem Injection Market Dynamics
9.1 Meropenem Injection Industry Trends
9.2 Meropenem Injection Market Drivers
9.3 Meropenem Injection Market Challenges
9.4 Meropenem Injection Market Restraints
10 Global Market Forecast
10.1 Meropenem Injection Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Meropenem Injection by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Meropenem Injection by Type (2023-2028)
10.2 Meropenem Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Meropenem Injection by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Meropenem Injection by Application (2023-2028)
10.3 Meropenem Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Meropenem Injection by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Meropenem Injection by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Meropenem Injection Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Meropenem Injection Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Meropenem Injection Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Meropenem Injection Market Competitive Situation by Manufacturers in 2021
Table 5. Global Meropenem Injection Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Meropenem Injection Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Meropenem Injection Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Meropenem Injection Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Meropenem Injection Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Meropenem Injection Manufacturing Sites and Area Served
Table 11. Manufacturers Meropenem Injection Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Meropenem Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meropenem Injection as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Meropenem Injection Sales by Region (2017-2022) & (K Units)
Table 16. Global Meropenem Injection Sales Market Share by Region (2017-2022)
Table 17. Global Meropenem Injection Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Meropenem Injection Revenue Market Share by Region (2017-2022)
Table 19. North America Meropenem Injection Sales by Country (2017-2022) & (K Units)
Table 20. North America Meropenem Injection Sales Market Share by Country (2017-2022)
Table 21. North America Meropenem Injection Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Meropenem Injection Revenue Market Share by Country (2017-2022)
Table 23. Europe Meropenem Injection Sales by Country (2017-2022) & (K Units)
Table 24. Europe Meropenem Injection Sales Market Share by Country (2017-2022)
Table 25. Europe Meropenem Injection Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Meropenem Injection Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Meropenem Injection Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Meropenem Injection Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Meropenem Injection Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Meropenem Injection Revenue Market Share by Region (2017-2022)
Table 31. Latin America Meropenem Injection Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Meropenem Injection Sales Market Share by Country (2017-2022)
Table 33. Latin America Meropenem Injection Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Meropenem Injection Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Meropenem Injection Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Meropenem Injection Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Meropenem Injection Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Meropenem Injection Revenue Market Share by Country (2017-2022)
Table 39. Global Meropenem Injection Sales by Type (2017-2022) & (K Units)
Table 40. Global Meropenem Injection Sales Market Share by Type (2017-2022)
Table 41. Global Meropenem Injection Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Meropenem Injection Revenue Share by Type (2017-2022)
Table 43. Global Meropenem Injection Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Meropenem Injection Sales (K Units) by Application (2017-2022)
Table 45. Global Meropenem Injection Sales Market Share by Application (2017-2022)
Table 46. Global Meropenem Injection Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Meropenem Injection Revenue Share by Application (2017-2022)
Table 48. Global Meropenem Injection Price by Application (2017-2022) & (US$/Unit)
Table 49. Pfizer Corporation Information
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Pfizer Meropenem Injection Product
Table 53. Pfizer Recent Developments/Updates
Table 54. AuroMedics Corporation Information
Table 55. AuroMedics Description and Business Overview
Table 56. AuroMedics Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. AuroMedics Meropenem Injection Product
Table 58. AuroMedics Recent Developments/Updates
Table 59. Sandoz Corporation Information
Table 60. Sandoz Description and Business Overview
Table 61. Sandoz Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Sandoz Meropenem Injection Product
Table 63. Sandoz Recent Developments/Updates
Table 64. Amneal Pharmaceuticals Corporation Information
Table 65. Amneal Pharmaceuticals Description and Business Overview
Table 66. Amneal Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Amneal Pharmaceuticals Meropenem Injection Product
Table 68. Amneal Pharmaceuticals Recent Developments/Updates
Table 69. Sumitomo Dainippon Pharma Corporation Information
Table 70. Sumitomo Dainippon Pharma Description and Business Overview
Table 71. Sumitomo Dainippon Pharma Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Sumitomo Dainippon Pharma Meropenem Injection Product
Table 73. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 74. Fresenius Kabi Corporation Information
Table 75. Fresenius Kabi Description and Business Overview
Table 76. Fresenius Kabi Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Fresenius Kabi Meropenem Injection Product
Table 78. Fresenius Kabi Recent Developments/Updates
Table 79. Mylan Corporation Information
Table 80. Mylan Description and Business Overview
Table 81. Mylan Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Mylan Meropenem Injection Product
Table 83. Mylan Recent Developments/Updates
Table 84. Sagent Pharmaceuticals Corporation Information
Table 85. Sagent Pharmaceuticals Description and Business Overview
Table 86. Sagent Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Sagent Pharmaceuticals Meropenem Injection Product
Table 88. Sagent Pharmaceuticals Recent Developments/Updates
Table 89. Bionova Scientific Corporation Information
Table 90. Bionova Scientific Description and Business Overview
Table 91. Bionova Scientific Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Bionova Scientific Meropenem Injection Product
Table 93. Bionova Scientific Recent Developments/Updates
Table 94. Macleods Pharmaceuticals Corporation Information
Table 95. Macleods Pharmaceuticals Description and Business Overview
Table 96. Macleods Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Macleods Pharmaceuticals Meropenem Injection Product
Table 98. Macleods Pharmaceuticals Recent Developments/Updates
Table 99. Johnlee Pharmaceuticals Corporation Information
Table 100. Johnlee Pharmaceuticals Description and Business Overview
Table 101. Johnlee Pharmaceuticals Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Johnlee Pharmaceuticals Meropenem Injection Product
Table 103. Johnlee Pharmaceuticals Recent Developments/Updates
Table 104. Xinya Pharm Corporation Information
Table 105. Xinya Pharm Description and Business Overview
Table 106. Xinya Pharm Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Xinya Pharm Meropenem Injection Product
Table 108. Xinya Pharm Recent Developments/Updates
Table 109. PKU HealthCare Corporation Information
Table 110. PKU HealthCare Description and Business Overview
Table 111. PKU HealthCare Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. PKU HealthCare Meropenem Injection Product
Table 113. PKU HealthCare Recent Developments/Updates
Table 114. United Laboratories Corporation Information
Table 115. United Laboratories Description and Business Overview
Table 116. United Laboratories Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. United Laboratories Meropenem Injection Product
Table 118. United Laboratories Recent Developments/Updates
Table 119. CSPC Group Corporation Information
Table 120. CSPC Group Description and Business Overview
Table 121. CSPC Group Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. CSPC Group Meropenem Injection Product
Table 123. CSPC Group Recent Developments/Updates
Table 124. Zhejiang Hisun Pharmaceutical Corporation Information
Table 125. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 126. Zhejiang Hisun Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Zhejiang Hisun Pharmaceutical Meropenem Injection Product
Table 128. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 129. Luoxin Pharmaceutical Corporation Information
Table 130. Luoxin Pharmaceutical Description and Business Overview
Table 131. Luoxin Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Luoxin Pharmaceutical Meropenem Injection Product
Table 133. Luoxin Pharmaceutical Recent Developments/Updates
Table 134. Hainan Haiyao Co., Ltd. Corporation Information
Table 135. Hainan Haiyao Co., Ltd. Description and Business Overview
Table 136. Hainan Haiyao Co., Ltd. Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Hainan Haiyao Co., Ltd. Meropenem Injection Product
Table 138. Hainan Haiyao Co., Ltd. Recent Developments/Updates
Table 139. Shenzhen Haibin Pharmaceutical Corporation Information
Table 140. Shenzhen Haibin Pharmaceutical Description and Business Overview
Table 141. Shenzhen Haibin Pharmaceutical Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Shenzhen Haibin Pharmaceutical Meropenem Injection Product
Table 143. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 144. Chongqin Shenghuaxi Corporation Information
Table 145. Chongqin Shenghuaxi Description and Business Overview
Table 146. Chongqin Shenghuaxi Meropenem Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Chongqin Shenghuaxi Meropenem Injection Product
Table 148. Chongqin Shenghuaxi Recent Developments/Updates
Table 149. Production Base and Market Concentration Rate of Raw Material
Table 150. Key Suppliers of Raw Materials
Table 151. Meropenem Injection Distributors List
Table 152. Meropenem Injection Customers List
Table 153. Meropenem Injection Market Trends
Table 154. Meropenem Injection Market Drivers
Table 155. Meropenem Injection Market Challenges
Table 156. Meropenem Injection Market Restraints
Table 157. Global Meropenem Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 158. Global Meropenem Injection Sales Market Share Forecast by Type (2023-2028)
Table 159. Global Meropenem Injection Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 160. Global Meropenem Injection Revenue Market Share Forecast by Type (2023-2028)
Table 161. Global Meropenem Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 162. Global Meropenem Injection Sales Market Share Forecast by Application (2023-2028)
Table 163. Global Meropenem Injection Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 164. Global Meropenem Injection Revenue Market Share Forecast by Application (2023-2028)
Table 165. Global Meropenem Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 166. Global Meropenem Injection Sales Market Share Forecast by Region (2023-2028)
Table 167. Global Meropenem Injection Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 168. Global Meropenem Injection Revenue Market Share Forecast by Region (2023-2028)
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Meropenem Injection
Figure 2. Global Meropenem Injection Market Share by Type in 2021 & 2028
Figure 3. 0.25g/vial Product Picture
Figure 4. 0.5g/vial Product Picture
Figure 5. 1g/vial Product Picture
Figure 6. Global Meropenem Injection Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Clinics
Figure 9. Others
Figure 10. Global Meropenem Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Meropenem Injection Market Size (2017-2028) & (US$ Million)
Figure 12. Global Meropenem Injection Sales (2017-2028) & (K Units)
Figure 13. Meropenem Injection Sales Share by Manufacturers in 2021
Figure 14. Global Meropenem Injection Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Meropenem Injection Players: Market Share by Revenue in 2021
Figure 16. Meropenem Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Meropenem Injection Sales Market Share by Region (2017-2022)
Figure 18. Global Meropenem Injection Sales Market Share by Region in 2021
Figure 19. Global Meropenem Injection Revenue Market Share by Region (2017-2022)
Figure 20. Global Meropenem Injection Revenue Market Share by Region in 2021
Figure 21. U.S. Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Taiwan Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Philippines Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Vietnam Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Meropenem Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Meropenem Injection by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Meropenem Injection
Figure 47. Manufacturing Process Analysis of Meropenem Injection
Figure 48. Meropenem Injection Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
  • Global Megestrol Acetate (Megace) Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 96
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Suspension - Tablets Segment by Application - Hospital - Clinic - Other ......
  • Global Oxcarbazepine Tablets Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 116
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tablets (150mg) - Tablets (300mg) - Tablets (600mg) Segment by Application - Hospital......
  • Global Oxcarbazepine API Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 116
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Medical Grade - Other Segment by Application - Tablets - Oral Suspension - Oth......
  • Global Therapeutic Dog Food Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 100
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Dry Food - Wet/Canned Food - Fresh Food - Snacks/treats - Others Segment by Ap......
  • Global Transtympanic Injectable Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 90
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Corticosteroid - Aminoglycosides Segment by Application - Hospitals - ENT Clinics......
  • Global Enzyme Indicators Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 119
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Bio-decontamination - Drug Development - Pesticide Synthesis Segment by Application -......
  • Global Stool Softeners Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 102
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Liquid - Softgel Capsule - Enema Segment by Application - Hospitals - Clinics......
  • Global Std Self Diagnostics Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Testing Kit - Testing Device - Testing Strip/chip Segment by Application - Hospitals......
  • Global Eye Drops for Contact Lens Market Research Report 2022
    Published: 18-Aug-2022        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - = 10ml - > 10ml Segment by Application - Online Channel - Offline Channel ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs